Finance PDP Netherlands at Abbott

Zwolle, Overijssel, Netherlands

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

NoVisa

HealthcareIndustries

Requirements

Completion of a bachelor’s degree in Finance, Accounting, Business or similar
Geographically mobile and willing to do one six-month assignment outside of home region
Unrestricted authorization to work in home country (within Europe)
Fluent level of English for written and verbal business communication
Desire to pursue certification as Qualified Accountant
Preferred Qualifications
Strong academic records
Demonstrated leadership through organizational involvement
Minimum of one internship in Finance or Accounting

Responsibilities

Participate in Abbott’s Financial Professional Development Program (FPDP) for two years
Complete four different six-month assignments across a variety of Abbott businesses and areas of Finance (e.g., corporate and division headquarters, manufacturing plants, operating environments)
Work in multiple locations worldwide (e.g., United States, United Kingdom, Ireland, The Netherlands, Switzerland, Germany, Singapore, Brazil, Costa Rica)
Engage with a senior financial leader for mentoring and advising
Upon program completion, collaborate with the Program Management Office to secure a role within Abbott in the home region

Skills

Accounting

Finance

Financial Planning

Financial Analysis

Business Analysis

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free